The Fred Hutch Antibody Technology Resource uses a ClonePix 2 as an integral
part of their hybridoma screening platform.
“The Antibody Technology Shared Resource at the Fred Hutch Cancer Research Center offers custom antibody development to academic and industrial research groups. Our unique multiplex screening platform incorporates a Molecular Devices ClonePix 2 for identifying and picking monoclonal hybridoma colonies that secrete antibody to specific protein, peptide, or small molecule targets. The ClonePix 2 has allowed us to completely redefine our project workflow and capacity.”